Why is parkinsonism not a feature of human methamphetamine users? - Wikidata - awgldk - TriplyDB

Why is parkinsonism not a feature of human methamphetamine users?

Why is parkinsonism not a feature of human methamphetamine users?

http://www.wikidata.org/entity/Q44673936

about

Abuse of amphetamines and structural abnormalities in the brain Neurologic manifestations of chronic methamphetamine abuse Methamphetamine toxicity and messengers of death Potential adverse effects of amphetamine treatment on brain and behavior: a review Methamphetamine effects on blood-brain barrier structure and function Pharmacotherapy for stimulant-related disorders Clinical imaging in regenerative medicine HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat Age-dependent effects of neonatal methamphetamine exposure on spatial learning.Functional and structural brain changes associated with methamphetamine abuse Dopamine transporter trafficking: rapid response on demand.Parkinsonism in patients with a history of amphetamine exposure.Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance Methamphetamine abuse, HIV infection, and neurotoxicity.Neurocognitive impairment and HIV risk factors: a reciprocal relationship.Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users.Methamphetamine influences on brain and behavior: unsafe at any speed?The need for speed: an update on methamphetamine addiction.Altered neurometabolites and motor integration in children exposed to methamphetamine in utero Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.Pharmacologic mechanisms of crystal meth.Brain levels of neuropeptides in human chronic methamphetamine users.Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response Neurologic manifestations of chronic methamphetamine abuse.Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.

P2860

Q22241673-732EB65E-5C5C-49C2-A3D5-610EBCE50A08 Q24624506-28441699-8CD8-41AA-AE78-B22FDD4AFC80 Q24647617-04F73F09-2801-44F8-9D69-79E1004F5A6E Q24657966-8FFF5ADB-6462-408E-B4A7-1DCC5E202B27 Q26825795-87CBDD3A-A1B0-4DE6-8C1A-DA7FF88398CD Q26829186-328E02D2-8E3B-47A5-980C-BAAFA463641B Q26851906-74506A85-445F-4770-9003-250ECB14F68D Q28392199-751989DB-B45C-4000-8ABE-74C281B7C489 Q28472559-5C2FB06C-1E8E-4955-970D-A2D26B2CA64C Q28751397-0DF5F1E5-B36C-4C35-BC11-8D6D4AC93B4A Q30833169-205FC8DF-B5B8-4B95-9377-6C4B896D4D2F Q33654916-476BF57F-2F71-489E-9F9D-1F01A54F9A2C Q33698983-6C164E3A-5E03-4A99-9A00-B6128ACF054C Q33772001-ACB1D9A4-FC90-4E8C-B92A-D45D98F34BAC Q33799373-86972CF4-A554-4DA0-B83E-E40FAF9BC389 Q34005620-7440F06B-0A74-4DBC-8A32-012142429989 Q34079192-D2972BEA-FB51-45A6-9CED-8E743D8DC182 Q34282453-CC1D6EDC-1BEC-40A9-A7E6-407011081F20 Q35012661-5E714D5A-8BC6-49A7-B90B-C4839ED8783F Q35124882-08503D07-D1ED-4B8D-A5D1-213919B333F7 Q35172603-F1A724F2-2C47-4162-8BB0-DD0E1332AC51 Q36241219-1AEAF996-FB90-4718-BB49-7DF76517FBC2 Q36453293-4A01C52D-2755-4EBA-BDCE-89D20FEA2D16 Q36493570-D353369F-3304-4E7C-B567-A8F7BE175445 Q36565693-FA294296-B8ED-4D9E-8031-BECA60CF9EB1 Q36700620-9FFA4BB9-E62A-4701-9298-BEE19DCD23D6 Q36852952-E93A034C-883B-41F9-885E-F985E64B33E2 Q36977879-3DB6CF6A-371A-46CE-9B37-564F4C74BD76 Q36983864-647AFD94-64F0-4F2A-921C-22ECE5D9FD61 Q37150547-8787B077-D708-4F38-ADAF-D7F466246E8F Q37180671-F823A2C4-B090-45C0-9E2A-9360AB91CE97 Q37314434-95D0F24A-752B-41C9-92AF-721634BE8157 Q37318253-18754A97-2AA4-48EE-87A3-6E10DE9AB5C1 Q37416424-D5B79A9B-BC54-47BA-BCA2-67B1B08391ED Q37661270-2F86CA0C-F4A2-4475-9A1D-6AA223405992 Q37727186-6FE98530-DDC9-44DF-9C6E-6D2E75038CE4 Q37909050-4D92D52B-396E-4152-B278-C58CFAD8539A Q38917424-85217427-E904-4F19-B051-09C577F3863C Q38926228-CD94C35F-385D-441F-8225-26FB3D253773 Q39153958-7FE8DDFB-F9D7-49EF-B648-1A1EF03A6DE4

P2860

Why is parkinsonism not a feature of human methamphetamine users?

http://www.wikidata.org/entity/Q44673936

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Why is parkinsonism not a feature of human methamphetamine users?

@en

Why is parkinsonism not a feature of human methamphetamine users?

@nl

type

label

Why is parkinsonism not a feature of human methamphetamine users?

@en

Why is parkinsonism not a feature of human methamphetamine users?

@nl

prefLabel

Why is parkinsonism not a feature of human methamphetamine users?

@en

Why is parkinsonism not a feature of human methamphetamine users?

@nl

P1433

Q44673936-0CC4AB98-38AA-4CF6-91EC-49F6428CDF74

P1476

Q44673936-0C216A58-6D87-4901-8295-4FA5DBE85C60

P2093

Q44673936-16F025E9-A055-43DE-8CB3-D8A378615379

Q44673936-23EDE599-2637-478F-A95E-E76DB0539799

Q44673936-7EDE2320-C773-491B-A8FF-0487684EDC5F

Q44673936-92A9E34E-0F84-4D83-8413-088178B53632

Q44673936-931B6FDA-7882-40BB-80F6-0B70B876FFFF

Q44673936-D5EB2312-D908-4116-AFAC-6993F65804B7

Q44673936-FB2D9D79-1B0B-4599-9179-14304B5A4839

P2860

Q44673936-05292A28-59B3-44EE-A5B2-5C2AB664A460

Q44673936-0605382A-2377-42E6-8731-EEE896ED79D8

Q44673936-0875F4EB-037D-443E-A57E-DA3A0D6FBDAC

Q44673936-0928637A-45F6-483F-A53A-5D9C3A58389B

Q44673936-18AA14B9-0CEC-445A-8E53-D98A4DFD06CB

Q44673936-326C5071-3D05-4DD2-8DB9-F842D84BDDE0

Q44673936-370F2DA9-E99C-4755-BEFA-7C402ACBB199

Q44673936-46045D6F-851E-46AD-8355-EE44700A0133

Q44673936-4D10AD56-8F13-4E50-904E-6A494472BD37

Q44673936-64268C4E-3006-4CB6-A819-09CEFD23D356

P304

Q44673936-180B9EA7-3995-4B9E-A739-0E795D201AA6

P31

Q44673936-BEC8A0E3-24ED-4C0A-B52E-281B5581F7CC

P356

Q44673936-D65191D6-E063-499B-AB96-3C51C5375F9F

P407

Q44673936-C90BBA5B-1E09-452C-B32A-50474C1B0B73

P433

Q44673936-50A5CAC6-92EC-4C2D-8988-30DBF0B24F7F

P478

Q44673936-85C60EC8-7B75-42F1-A36E-5116D8F657E6

P50

Q44673936-0EB02F98-74BF-47D9-9596-374666593418

Q44673936-E9D2E4D2-A988-4D18-9748-E8872C947315

P577

Q44673936-E161E982-03BA-40B9-B130-65D0919C8285

P5875

Q44673936-BFB3DED0-BC94-4F59-BBD0-8A0373849595

P698

Q44673936-AC8CBA45-3EA5-4FE4-8C18-CED76D3822AD

P921

Q44673936-A905C5BC-FC5F-4B76-8C17-7C8AB10E532C

Q44673936-F9CD04F1-EBA5-4057-BAA5-9551C765751D

P356

P1433

P1476

Why is parkinsonism not a feature of human methamphetamine users?

@en

P2093

Dennis J Wickham

http://www.w3.org/2001/XMLSchema#string

Frank J Peretti

http://www.w3.org/2001/XMLSchema#string

Gregory A Schmunk

http://www.w3.org/2001/XMLSchema#string

Kathryn S Kalasinsky

http://www.w3.org/2001/XMLSchema#string

Lee Ang

http://www.w3.org/2001/XMLSchema#string

Sally S Aiken

http://www.w3.org/2001/XMLSchema#string

Stephen J Kish

http://www.w3.org/2001/XMLSchema#string

P2860

Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure.

Cognitive impairment in individuals currently using methamphetamine.

Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users.

Neurobiology of addiction.

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans.

An extrapyramidal choreiform syndrome caused by amphetamine addiction.

Electron microscopic evidence for neurotoxicity in the basal ganglia.

An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.

P304

363-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWH046

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Anna Moszczynska

Paul S. Fitzmaurice

P577

2003-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8985685

http://www.w3.org/2001/XMLSchema#string

P698

14645148

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

D-methamphetamine